Browsing by Author "Casanello Toledo, Paola Cecilia"

Now showing 1 - 6 of 6
  • Thumbnail Image
    Item
    Epigenética en enfermedades alérgicas y asma
    (2016) Castro Rodríguez, José Antonio; Krause Leyton, Bernardo; Uauy, Ricardo; Casanello Toledo, Paola Cecilia
    Las enfermedades alérgicas y el asma son el resultado de complejas interacciones entre la predisposición genética y factores ambientales. El asma es una de las enfermedades crónicas más prevalentes en niños. En este artículo se revisan algunos factores ambientales como la exposición a alérgenos, tabaco, bacterias, componentes microbianos, dieta, obesidad y estrés, que intervienen durante la vida intrauterina y la infancia en la regulación epigenética de las enfermedades alérgicas y el asma. La revisión se realiza en tres tipos de modelos: in-vitro, animales y humanos.
  • Thumbnail Image
    Item
    Growth patterns in infants born to women with pregestational overweight/obesity supplemented with docosahexaenoic acid during pregnancy
    (2024) De Toro Navarrete, Valeria Francisca; Alberti, Gigliola; Domínguez, Angélica; Carrasco Negüe, Karina Andrea; Ferrer, Pedro; Valenzuela, Rodrigo; Garmendia. María Luisa; Casanello Toledo, Paola Cecilia
    Background: Previous studies of maternal docosahexaenoic acid (DHA) supplementation during pregnancy have controversial and contrasting results on the short and long-term effects on early child growth. The impact of this nutritional intervention on the postnatal growth patterns in the offspring of women with pregestational overweight/obesity (PGO) also remains controversial. Objective: To analyze the postnatal growth patterns during the first 4 months of life in the offspring of women with PGO randomly supplemented with 800 mg/day (PGO-800) compared with normative doses of 200 mg/day (PGO-200) of DHA during pregnancy (<15 weeks of gestation until delivery). Methods: This study evaluated the growth patterns during the first 4 months of life of 169 infants of the women that participated in the MIGHT study (NCT02574767). We included the infants of women from the PGO-200 (n = 81) and PGO-800 group (n = 88). The growth patterns (weight, length, and head circumference) and change in z-score (WHO charts) were evaluated. Results: Throughout the first 4 months of life, the infants of the PGO-800 group had lower weight-for-length z-score (coef. −0.65, 95% confidence interval [CI] −1.07, −0.22, p = 0.003) and lower body mass index-for-age z-score (coef. −0.56, 95% CI −0.99, −0.12, p = 0.012) compared with the PGO-200 group adjusted by maternal body mass index, gestational weight gain, gestational age, insulin in cord blood and infant feeding (exclusive breastfed, not breastfed, and partially breastfed). Conclusions: Maternal supplementation with DHA during pregnancy could beneficially limit the offspring's postnatal weight gain during the first 4 months of life.
  • Thumbnail Image
    Item
    Hypoxia increases equilibrative nucleoside transporter 2 activity by a transcriptional independent mechanism in human umbilical vein endothelium
    (2006) Torres, A; San Martin, R; Farías Jofré, Marcelo Enrique; Sobrevía Luarte, Luis Alberto; Casanello Toledo, Paola Cecilia
    Low oxygen tension (hypoxia) reduces adenosine transport in several types of mammalian cells. Adenosine transport is mediated by human equilibrative nucleoside transporter 1 (hENT1) and hENT2 in human umbilical vein endothelium (HUVEC), a fetal cell type that grows under 5% O2 (ie. normoxia for this cell type). We studied whether hypoxia alters hENT2 expression and activity in HUVEC. Methods: Cells were cultured (0-24 h) in 5% or 2% O2 (hypoxia), and [3H]adenosine uptake (125 and 500 μM, 4 μCi/ml, 20 s, 37°C) was measured in absence or presence of 100 nM nitrobenzylthioinosine (NBMPR, hENT1 inhibitor). hENT2 mRNA was quantified by real time RT-PCR, and protein abundance was determined by Western blot. SLC29A2 (for hENT2) promoter activity was measured following transfection (electroporation, 320 V, 30 ms) with pGL3 basic plasmid (firefly/renilla luciferase reporter gene) carrying -1477 bp and -587 bp of the promoter sequence. Results: Hypoxia reduced hENT2 mRNA expression (~55%), and promoter activity (~50%), but did not alter hENT2 protein abundance. Adenosine uptake via hENT2 was increased (2-fold) in hypoxia. Conclusions: Adenosine uptake via hENT2 may be modulated by post-translational mechanisms in hypoxia in HUVEC. Supported by FONDECYT 1030781/1030607/7050030. A Torres holds a School of Medicine research fellowship, and M Farías holds a CONICYT-PhD fellowship.
  • Thumbnail Image
    Item
    IL-10 expression in macrophages from neonates born from obese mothers is suppressed by IL-4 and LPS/INFγ
    (2017) Cifuentes Zuniga, Francisca; Arroyo Jousse, Viviana; Soto Carrasco, Gustavo; Casanello Toledo, Paola Cecilia; Uauy, Ricardo; Krause Leyton, Bernardo; Castro Rodríguez, José Antonio
  • Thumbnail Image
    Item
    Pre-gestational overweight in guinea pig sows induces fetal vascular dysfunction and increased rate of large and small fetuses
    (2016) Krause Leyton, Bernardo; Herrera, E. A.; Díaz López, F. A.; Farías Jofré, Marcelo Enrique; Uauy, Ricardo; Casanello Toledo, Paola Cecilia
  • No Thumbnail Available
    Item
    The transcriptional repression of equilibrative nucleoside transporter 1 by D-glucose rfsponses to transcription factor Sp1 and ZBP-89 in human foetal endothelium
    (2008) Puebla Aracena, Carlos Alberto; Farías Jofré, Marcelo Enrique; Vega Pizarro, José Luis Eduardo; Pastor-Anglada, M.; Casanello Toledo, Paola Cecilia; Sobrevía Luarte, Luis Alberto
    Objectives: Adenosine is a vasodilator in most vascular beds, an effect depending on its extracellular concentration. Uptake of this nucleoside in human umbilical vein endothelial cells (HUVEC) is mainly mediated by human equilibrative nucleoside transporters 1 (hENT1). hENT1 expression and transport activity are reduced in HUVEC exposed to high D-glucose. Since specific mechanisms for these effects of D-glucose are unknown, we examined the role of Sp1 and BP-89 transcription factors on SLC29A1 (for hENT1) promoter activity in response to D-glucose. Methods: HUVEC from normal pregnancies were isolated and exposed (24 h) to 5 mM (normal) or 25 mM (high) D-glucose. Sp1 protein levels were evaluated by western blot in nuclear fractions. Reporter activity of plasmid constructs containing a wild type promoter region of SLC29A1 (-1114 bp to ATG, pGL3-hENT1-1114), or mutations (by PCR) for Sp1 (-815/-801 bp, pGL3-hENT1-1114mutSp1) or ZBP-89 (-992/-969 bp, pGL3-hENT1-1114mutZBP) or both (-1114 bp, pGL3-hENT1-1114mutSp1/ZBP) binding sites were assayed in cells over-expressing Sp1 (using pCGN-Sp1 vector). Results: Nuclear Sp1 abundance was increased, but pGL3-hENT1-1114 transcriptional activity was reduced by high D-glucose. Sp1 over-expression reduced pGL3-hENT1-1114 transcriptional activity in normal or high D-glucose. The effect of high D-glucose or Sp1 over-expression was absent in pGL3-hENT1-1114mutSp1, pGL3-hENT1-1114mutZBP and pGL3-hENT1-1114mutSp1/ZBP cells. Conclusion: A repression of the SLC29A1 promoter activity by Sp1 and ZBP-89 could explain the reduced hENT1 expression and activity exhibited by HUVEC in high extracellular D-glucose. FONDECYT 1070865/1080534/7070249 (Chile), AECI A/5484/06 (Spain). C Puebla andJL Vega hold CONICYT fellowships. M Farías holds CONICYT and PUC-School of Medicine PhD fellowships.